Bodhi Tree Biotechnology Files IPO Amendment
Ticker: BDTB · Form: S-1/A · Filed: Feb 21, 2025 · CIK: 2041531
Sentiment: neutral
Topics: ipo, sec-filing, amendment
TL;DR
Bodhi Tree Biotech filed an S-1/A, moving closer to IPO. Watch for their next move.
AI Summary
Bodhi Tree Biotechnology Inc. filed an S-1/A amendment on February 21, 2025, for its initial public offering. The company, incorporated in Delaware, is based in Danville, CA, and operates in management consulting services. This filing updates its registration statement, indicating progress towards a public offering.
Why It Matters
This S-1/A filing signifies Bodhi Tree Biotechnology's progression towards becoming a publicly traded company, which could impact its funding, operations, and the biotechnology sector.
Risk Assessment
Risk Level: medium — As an S-1/A filing, it indicates a company is in the process of going public, which inherently carries risks associated with market volatility and business execution.
Key Numbers
- 333-284678 — SEC File Number (Identifies the specific registration statement with the SEC.)
- 25653190 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- Bodhi Tree Biotechnology Inc. (company) — Registrant
- 8748 (dollar_amount) — Primary Standard Industrial Classification Code Number
- 93-4908449 (dollar_amount) — I.R.S. Employer Identification No.
- 4125 Blackhawk Plaza Circle, Suite 172 (company) — Registrant's principal executive offices address
- Danville, CA 94506 (company) — Registrant's principal executive offices city, state, zip
- (925)406-4528 (company) — Registrant's principal executive offices telephone number
- Cassi Olson, Esq. (person) — Copy to contact
- Celine and Partners, P.L.L.C. (company) — Legal counsel
- 1185 6th Ave., Suite 304 (company) — Legal counsel address
- New York, NY 10036 (company) — Legal counsel city, state, zip
FAQ
What is the primary business of Bodhi Tree Biotechnology Inc.?
Bodhi Tree Biotechnology Inc. is primarily involved in Services-Management Consulting Services, as indicated by its SIC code 8742.
When was this amendment to the registration statement filed?
This amendment (S-1/A) was filed with the SEC on February 21, 2025.
Where is Bodhi Tree Biotechnology Inc. headquartered?
The company's principal executive offices are located at 4125 Blackhawk Plaza Circle, Suite 172, Danville, CA 94506.
What is the SEC file number associated with this registration statement?
The SEC file number for this registration statement is 333-284678.
Who is listed as the agent for service for this filing?
Cassi Olson, Esq. from Celine and Partners, P.L.L.C. is listed as the agent for service.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on February 21, 2025 by Cassi Olson, Esq. regarding Bodhi Tree Biotechnology Inc (BDTB).